Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 57.27 | N/A |
| PEG Ratio (TTM) | 1.65 | N/A |
| P/S Ratio (TTM) | 6.57 | N/A |
| P/B Ratio (TTM) | 1.64 | N/A |
| P/FCF Ratio (TTM) | 13.88 | N/A |
| Price to 5YR AVG Earnings Ratio | 129.10 | N/A |
| Price to 5YR AVG FCF Ratio | 40.12 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.23% | N/A |
| ROE (TTM) | 3.01% | N/A |
| Net Profit Margin (TTM) | 11.47% | N/A |
| ROIC 5YR AVG | 5.32% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 435.95% | 16.69% | 159.37% |
| Revenue | 90.22% | 2.75% | 67.49% |
| Net Income | 499.91% | 24.48% | 166.36% |
| Cash Flow | 88.71% | 6.16% | 58.58% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.63 | N/A |
| Quick Ratio (TTM) | 0.63 | N/A |
| D/E Ratio (TTM) | 1.00 | N/A |
| Interest Coverage (TTM) | 1.85 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.93 | N/A |
| LTL to 5YR AVG FCF | 20.17 | N/A |
| Shares Outstanding Growth 5YR AVG | 22.96% | N/A |